SCHEMBL16239630

SCHEMBL16239630

CC1(C)CC(c2cccc(NC3(C(=O)O)CC3)c2)Nc2c(OC(=O)O)cccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16239484 0.89 — —
SCHEMBL2134178 0.85 MEN1 (0.38) —
SCHEMBL16239855 0.83 — —
SCHEMBL2134792 0.81 NPC1 (0.31) —
SCHEMBL2134564 0.79 GRIN2B (0.36) —
SCHEMBL2137124 0.79 F11 (0.35) —
SCHEMBL2136073 0.77 PRKAG1 (0.37) —
SCHEMBL2133024 0.76 GRIN2B (0.35) —
SCHEMBL2138497 0.75 HSPA9 (0.39) —
SCHEMBL2135981 0.75 F10 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2630124-B1 TETRAHYDROQUINOLINE DERIVATIVES USED AS AMPK ACTIVATORS HOFFMANN LA ROCHE (CH) 2014-11-19 — — EP claimed
Send feedback